Burçin BEKEN, Mehtap YAZICIOĞLU, Ibon Eguiluz-GRACIA, Paloma CAMPO

Local allergic rhinitis: a pediatric perspective

Local allergic rhinitis (LAR) is a differentiated rhinitis phenotype defined by perennial or seasonal rhinitis symptoms without systemic atopy. The diagnosis can be made by a positive response to the nasal allergen challenge (NAC) (the gold standard for diagnosis) in the absence of skin prick test and/or serum allergen-specific immunoglobulin E.Clinical and epidemiological studies have demonstrated that LAR affects individuals from different countries, races, and age ranges. Several studies have shown that the onset of nasal symptoms occurs during childhood in a significant proportion of LAR individuals. Evidence of LAR has been growing, especially in pediatric and Asian populations. A review of the literature reveals that most LAR studies of pediatric populations have appeared in the last three years. The prevalence of LAR in children ranges from 3.7% to 66.6%, and similar to what has been observed in adults, prevalence is higher in Western countries. Publications have shown that LAR in children can be either seasonal or perennial, and diagnosis of LAR confirmed by NAC have been reported with numerous allergens (house dust mites, pollens, molds, and dander).These findings illustrate that LAR is an important differential diagnosis in children with presumed non-allergic rhinitis, and a through review of the very recent literature can contribute to the clinical identification and diagnosis of LAR in children with no evidence of systemic atopy, as well as update readers’ knowledge of the topic.

PDF

___

1.Roberts G, Xatzipsalti M, Borrego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2013; 68: 1102-1116.
2.Togias A. Non allergic rhinitis. In: Akdis CA, Hellings PW, Agache I (eds). Spain: Global atlas of Allergic Rhinitis and Chronic Rhinosinusitis, 2015: 234-236.
3.Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet 2011; 378: 2112-2122.
4.Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy 2017; 72: 1657-1665.
5.Papadopoulos NG, Guibas GV. Rhinitis subtypes, endotypes, and definitions. Immunol Allergy Clin North Am 2016; 36: 215-233.
6.Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979; 122: 2218-2225.
7.Ait Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J; ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64: 123-148.
8.Kurukulaaratchy RJ, Karmaus W, Raza A, Matthews S, Roberts G, Arshad SH. The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. Clin Exp Allergy 2011; 41: 851-859.
9.Rochat MK, Illi S, Ege MJ, et al; Multicentre Allergy Study (MAS) Group. Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol 2010; 126: 1170-1175. e2.
10.Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. 'Entopy': localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003; 33: 1374-1379.
11.Rondón C, Fernández J, López S, et al. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol 2009; 124: 1005-1011.e1.
12.Rondón C, Doña I, López S, et al. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Allergy 2008; 63: 1352-1358.
13.Rondón C, Romero JJ, López S,et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007; 119: 899-905.
14.Samter M, Becker EL. Ragweed reagins in nasal secretion. Proc Soc Exp Biol Med 1947; 65: 140.
15.Tse KS, Wicher K, Arbesman CE. IgE antibodies in nasal secretions of ragweed-allergic subjects. J Allergy 1970; 46: 352-357.
16.Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet 1975; 26: 148-150.
17.Deuschl H, Johansson SG. Specific IgE antibodies in nasal secretion from patients with allergic rhinitis and with negative or weakly positive RAST on the serum. Clin Allergy 1977; 7: 195-202.
18.Durham SR, Gould HJ, Thienes CP, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997; 27: 2899-2906.
19.Coker HA, Durham SR, Gould HJ. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003; 171: 5602-5610.
20.Bousquet J, Khaltaev N, Cruz AA, et al; World Health Organization; GA(2)LEN; AllerGenAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(Suppl 86): 8-160.
21.Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001; 31: 864-872.
22.Powe DG, Huskisson RS, Carney AS, et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy 2004; 59: 204-212.
23.Blom HM, Godthelp T, Fokkens WJ, et al. Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol 1995; 252(Suppl 1): S33-S39.
24.van Rijswijk JB, Blom HM, KleinJan A, Mulder PGH, Rijntjes E, Fokkens WJ. Inflammatory cells seem not to be involved in idiopathic rhinitis. Rhinology 2003; 41: 25-30.
25.Ersoy R, Ünsel M, Ardeniz FÖ, et al. The role of nasal provocation test in the differential diagnosis of allergic and non-allergic rhinitis. Asthma Allergy Immunol 2012; 10: 143-148.
26.Carney AS, Powe DG, Huskisson RS, Jones NS. Atypical nasal challenges in patients with idiopathic rhinitis: more evidence for the existence of allergy in the absence of atopy? Clin ExpAllergy 2002; 32: 1436-1440.
27.López S, Rondón C, Torres MJ, et al. Immediate and dual response to nasal challenge with dermatophagoides pteronyssinus in local allergic rhinitis. Clin Exp Allergy 2010; 40: 1007-1014.
28.Rondón C, Campo P, Zambonino MA, et al. Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis. J Allergy Clin Immunol 2014; 133: 1026-1031.
29.Rondon C, Campo P, Eguiluz-Gracia I, et al. Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study. Allergy 2018; 73: 470-478.
30.Arasi S, Pajno GB, Lau S, Matricardi PM. Local allergic rhinitis: a critical reappraisal from a paediatric perspective. Pediatr Allergy Immunol 2016; 27: 569-573.
31.Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130: 894-901.e5.
32.Campo P, Eguiluz-Gracia I, Plaza-Serón MC, et al. Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis. Allergy 2019; 74: 1502-1510.
33.Rondón C, Campo P, Galindo L, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy 2012; 67: 1282-1288.
34.Yamana Y, Fukuda K, Ko R, Uchio E. Local allergic conjunctivitis: a phenotype of allergic conjunctivitis. Int Ophthalmol 2019; 39: 2539-2544.
35.Fuiano N, Fusilli S, Passalacqua G, Incorvaia C. Allergen-specific immunoglobulin E in the skin and nasal mucosa of symptomatic and asymptomatic children sensitized to aeroallergens. J Investig Allergol Clin Immunol 2010; 20: 425-430.
36.Fuiano N, Fusilli S, Incorvaia C. A role for measurement of nasal IgE antibodies in diagnosis of alternaria-induced rhinitis in children. Allergol Immunopathol (Madr) 2012; 40: 71-74.
37.Buntarickpornpan P, Veskitkul J, Pacharn P, et al. The proportion of local allergic rhinitis to dermatophagoides pteronyssinus in children. Pediatr Allergy Immunol 2016; 27: 574-579.
38.Duman H, Bostanci I, Ozmen S, Dogru M. The relevance of nasal provocation testing in children with nonallergic rhinitis. Int Arch Allergy Immunol 2016; 170: 115-121.
39.Zicari AM, Occasi F, Di Fraia M, et al. Local allergic rhinitis in children: novel diagnostic features and potential biomarkers. A J Rhinol Allergy 2016; 30: 329-334.
40.Krajewska-Wojtys A, Jarzab J, Gawlik R, Bozek A. Local allergic rhinitis to pollens is underdiagnosed in young patients. AmJ Rhinol Allergy 2016; 30: 198-201.
41.Blanca-Lopez N, Campo P, Salas M, Rodriguez CG, et al. Seasonal local allergic rhinitis in areas with high concentrations of grass pollen. J Invest Allergol Clin Immunol 2016; 26: 83-91.
42.Ha EK, Na MS, Lee S, et al. Prevalence and clinical characteristics of local allergic rhinitis in children sensitized to house dust mites. Int Arch Allergy Immunol 2017; 174: 183-189.
43.Tsilochristou O, Kyriakakou M, Manolaraki I, et al. Detection of local allergic rhinitis in children with chronic, difficult-to-treat, non-allergic rhinitis using Multiple Nasal Provocation Tests. Pediatr Allergy Immunol 2019; 30: 296-304.
44.van Hage-Hamsten M, Pauli G. Provocation testing with recombinant allergens. Methods 2004; 32: 281-291.
45.Rondón C, Campo P, Herrera R, et al. Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis. J Allergy Clin Immunol 2011; 128: 1192-1197.
46.Campo P, Villalba M, Barrionuevo E, et al. Immunologic responses to the major allergen of Olea europaea in local and systemic allergic rhinitis subjects. Clin Exp Allergy 2015; 45: 1703-1712.
47.Bachert C. Nasal provocation test: critical evaluation. In: New Trends in Allergy IV: Springer; 1997:277-280.
48.Augé J, Vent J, Agache I, et al. EAACI position paper on the standardization of nasal allergen challenges. Allergy 2018; 73: 1597-1608.
49.Eguiluz-Gracia I, Testera-Montes A, Gonzalez M, et al. Safety and reproducibility of nasal allergen challenge. Allergy 2019; 74: 1125-1134.
50.Meng Y, Wang Y, Lou H, et al. Specific immunoglobulin E in nasal secretions for the diagnosis of local allergic rhinitis. Rhinology 2019; 57: 313-320.
51.Rondon C, Eguiluz-Gracia I, Shamji MH, et al. IgE test in secretions of patients with respiratory allergy. Curr Allergy Asthma Rep 2018; 18: 67.
52.Campo P, Del Carmen Plaza-Seron M, Eguiluz-Gracia I, et al. Direct intranasal application of the solid phase of ImmunoCAP® increases nasal specific immunoglobulin E detection in local allergic rhinitis patients. Int Forum Allergy Rhinol 2018; 8: 15-19.
53.Gomez E, Campo P, Rondón C, et al. Role of the basophil activation test in the diagnosis of local allergic rhinitis. J Allergy Clin Immunol 2013; 132: 975-976.e1-e5.
54.Gelardi M, Guglielmi AVN, Iannuzzi L, et al. Local allergic rhinitis: entopy or spontaneous response? World Allergy Organ J 2016; 9: 39.
55.Lee KS, Yu J, Shim D, et al. Local immune responses in children and adults with allergic and nonallergic rhinitis. PLoS One 2016; 11: e0156979.
56.Keswani A, Peters AT. Complications of rhinitis. Immunol Allergy Clin North Am 2016; 36: 359-366.
57.Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy 2012; 67: 91-98.
58.Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007; 120: 863-869.
59.Eguiluz-Gracia I, Pérez-Sánchez N, Bogas G, Campo P, Rondon C. How to diagnose and treat local allergic rhinitis: achallenge for clinicians. J Clin Med 2019; 8: 1062.
60.Rondón C, Blanca-López N, Aranda A, et al. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen. J Allergy Clin Immunol 2011; 127: 1069-1071.
61.Rondón C, Campo P, Blanca-Lopez N, et al. Subcutaneous allergen immunotherapy in patient with “Local Allergic Rhinitis” sensitized to dermatophagoides pteronyssinus. J Allergy Clin Immunol 2015; 135: AB171.
62.Rondón C, Blanca-López N, Campo P, et al. Specific immunotherapy in local allergic rhinitis: a randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy. Allergy 2018; 73: 905-915.
63.Bozek A, Kolodziejczyk K, Krajewska-Wojtys A, Jarzab J. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass. Ann Allergy Asthma Immunol 2016; 116: 156-161.